Iron Triangle Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-500,000
Closed -$27.4M 33
2025
Q3
$27.4M Buy
500,000
+200,000
+67% +$9.99M 3.89% 11
2025
Q2
$15.9M Buy
+300,000
New +$15.2M 2.45% 18
2025
Q1
Sell
-600,000
Closed -$33.7M 28
2024
Q4
$33.7M Buy
600,000
+200,129
+50% +$12.5M 3.71% 14
2024
Q3
$27.2M Buy
+399,871
New +$22.6M 3.77% 12
2024
Q2
Sell
-700,000
Closed -$48.3M 32
2024
Q1
$48.3M Buy
+700,000
New +$44.3M 4.95% 6
2023
Q4
Sell
-250,000
Closed -$17.1M 29
2023
Q3
$17.1M Sell
250,000
-250,000
-50% -$21.2M 2.49% 19
2023
Q2
$47M Buy
+500,000
New +$39M 6.28% 4
2021
Q2
Sell
-100,000
Closed -$13.2M 27
2021
Q1
$13.2M Sell
100,000
-400,000
-80% -$54.8M 1.68% 22
2020
Q4
$66.2M Buy
+500,000
New +$60.5M 8.59% 1
2020
Q1
Sell
-139,900
Closed -$12.9M 29
2019
Q4
$12.9M Buy
+139,900
New +$12.3M 3.43% 14

Other funds holding EXAS

Iron Triangle Partners's EXAS Position: Q4 2025 in Review

Iron Triangle Partners sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 500,000 shares — an estimated $27.4M sold.

Iron Triangle Partners first reported a position in EXAS in Q4 2019 and held it in 10 quarters. The position peaked at $66.2M in Q4 2020. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Iron Triangle Partners reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Iron Triangle Partners sold 500,000 Exact Sciences shares in Q4 2025, an estimated $27.4M.
  • Iron Triangle Partners first reported a position in Exact Sciences in Q4 2019 and held it in 10 quarters.
  • Iron Triangle Partners's Exact Sciences position peaked at $66.2M in Q4 2020.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Iron Triangle Partners's 13F filing for Q4 2025, filed 17 Feb 2026.